Statin intolerance and new lipid-lowering treatments

Cleve Clin J Med. 2021 Jul 1;88(7):381-387. doi: 10.3949/ccjm.88a.20165.

Authors

Oltion Mesi¹, Charlie Lin¹, Haitham Ahmed², Leslie S Cho³

Affiliations

¹ Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH.
² AdvantageCare Physicians, New York, NY.
³ Section Head, Preventive Cardiology and Cardiac Rehabilitation, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH chol@ccf.org.

PMID: 34210712
DOI: 10.3949/ccjm.88a.20165

No abstract available

MeSH terms

Anticholesteremic Agents* / adverse effects
Cardiovascular Diseases* / chemically induced
Cardiovascular Diseases* / prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Lipids

Substances

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids